London at the NextGen Omics, Spatial and Data Symposium 2025

Last week, Yi-Fang Wang and Laura Woods from our bioinformatics team had an inspiring time in London at the NextGen Omics, Spatial and Data Symposium 2025, one of the most forward-looking meetings on AI and machine learning in drug discovery.

It‘s great to see the growing momentum across the healthcare ecosystem to accelerate data-driven discovery, advance single-cell spatial multi-omics technologies, utilise liquid biopsy and develop precision medicines. Antisense approaches, including our MISBA® ASOs, clearly stood out as a promising therapeutic direction attracting increased interest.

Unlocking the full potential of AI and machine learning for complex diseases like neurodegeneration will require smarter automation, better connected data, and robust, reliable workflows to deliver faster and more precise scientific insights.
At Harness Therapeutics, our proprietary bioinformatics tool is at the core of our MISBA® platform. Working alongside advanced RNA analytics, cell line data and patient-derived datasets, it enables us to identify hotspots across entire mRNA sequences, helping us select the most effective therapeutic targets for precise up or down regulation.

hashtag#HarnessTherapeutics hashtag#MISBA hashtag#HuntingtonsDisease hashtag#NeurodegenerativeDiseases